Method for generating singlet oxygen, system for generating singlet oxygen, kit for generating singlet oxygen, and agent for generating singlet oxygen
By employing crystalline phthalocyanine compounds with controlled crystallinity and X-ray irradiation, the method enhances singlet oxygen generation efficiency, overcoming penetration limitations and source inefficiencies in existing technologies.
Patent Information
- Application Number
- JP2024062199
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-04-25
- Filing Date
- 2024-04-08
- Publication Date
- 2024-11-07
AI Technical Summary
Existing methods for generating singlet oxygen face limitations in penetration depth due to absorption by biological media and lack of efficient monochromatic X-ray sources, leading to insufficient generation of singlet oxygen in target areas.
A method involving the use of crystalline phthalocyanine compounds with controlled crystallinity, irradiated by electromagnetic radiation, particularly X-rays, to enhance singlet oxygen generation by optimizing triplet exciton propagation.
The method significantly increases the generation of singlet oxygen compared to conventional methods by improving the efficiency of triplet exciton propagation within the crystalline structure.
Smart Images

Figure 2024157523000001_ABST
Abstract
Description
[Technical field]
[0001] The present disclosure relates to a method for generating singlet oxygen, a system for generating singlet oxygen, a kit for generating singlet oxygen, and a singlet oxygen generator. [Background technology]
[0002] Singlet oxygen, a type of reactive oxygen, is used for the oxidative decomposition of organic matter, killing viruses and bacteria, and killing cancer cells in the body due to its high reactivity and oxidizing power. Methods for generating singlet oxygen include chemical methods such as reacting an aqueous hydrogen peroxide solution made alkaline with potassium hydroxide with chlorine gas, or using an excited oxygen generator with a chemical oxygen iodine laser. Alternatively, a simpler method is a photochemical method in which singlet oxygen is generated by intersystem crossing between dye molecules that have been excited into a triplet state by electromagnetic waves such as light and oxygen molecules. An example of the latter method is photodynamic therapy, which is a cancer cell killing therapy using singlet oxygen. Specific examples of dye molecules include porphyrin compounds and phthalocyanine compounds.
[0003] However, this conventional singlet oxygen generation method requires visible light or infrared light to excite the dye, so in practice it is limited to only being usable in areas where the excitation light can be irradiated. This is particularly problematic when there is a medium surrounding the dye that blocks the excitation light. For example, in photodynamic therapy, the challenge is how to irradiate sufficient excitation light deep inside the body. In order to solve this problem, attempts have been made to design dye molecules that are highly permeable through living organisms and can be excited by light of longer wavelengths.
[0004] In addition, in search of an excitation means with higher medium permeability, excitation by X-rays has also been attempted. In addition to a method of directly exciting dye molecules such as porphyrin with X-rays (Patent Document 1), there is a method of absorbing X-rays by heavy elements near the dye and exciting the dye with excitation light from the excited heavy elements (Patent Document 2). In addition, a method of exciting dyes with Auger electrons generated by irradiating heavy elements with X-rays is also known (Patent Document 3). [Prior art documents] [Patent documents]
[0005] [Patent Document 1] JP 2009-155239 A [Patent Document 2] Special Publication No. 2010-523690 [Patent Document 3] Special Publication No. 2017-532340 Summary of the Invention [Problem to be solved by the invention]
[0006] However, when using visible light or infrared light as the current excitation method, even if the wavelength of the excitation light is increased, it is impossible to avoid absorption by media such as the human body, and the amount of singlet oxygen generated in the target area does not necessarily satisfy the amount required for the application. In addition, when X-rays are used as an excitation method, there is a problem that there are currently no monochromatic X-ray sources that are widely used and highly practical in society, and only so-called white light sources with continuous wavelengths are available. Therefore, excitation by these X-ray irradiation has a lower excitation efficiency than light excitation using monochromatic light sources, and a means for increasing the amount of singlet oxygen generated has been required.
[0007] At least one aspect of the present disclosure solves the above problems and increases the amount of singlet oxygen generated compared to conventional methods. The present invention is directed to providing a method for generating singlet oxygen, which can increase the amount of singlet oxygen present. Moreover, at least one aspect of the present disclosure is directed to providing a singlet oxygen generating system that can solve the above problems and increase the amount of singlet oxygen generated compared to conventional systems. Furthermore, at least one aspect of the present disclosure is directed to providing a singlet oxygen generating kit that can solve the above problems and increase the amount of singlet oxygen generated compared to conventional methods. Moreover, at least one aspect of the present disclosure is directed to providing a singlet oxygen generator that can solve the above problems and increase the amount of singlet oxygen generated compared to conventional methods. [Means for solving the problem]
[0008] According to at least one aspect of the present disclosure, A method for generating singlet oxygen, comprising the steps of: The generating method includes a step of generating singlet oxygen by irradiating a crystal of a phthalocyanine compound with electromagnetic radiation, In an X-ray diffraction pattern of the crystals of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak exists within a diffraction angle range of 2θ=5° to 35°, The method for generating singlet oxygen is characterized in that the half-width of the most intense peak within the range is 2.50° or less.
[0009] According to another aspect of the present disclosure, A crystal of a phthalocyanine compound; an apparatus having a source for irradiating the crystal with electromagnetic radiation; Equipped with In an X-ray diffraction pattern of a crystal of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak is present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the most intense peak within the range is 2.50° or less; Singlet oxygen is generated from the crystal. A system for generating singlet oxygen is provided.
[0010] According to another aspect of the present disclosure, A crystal of a phthalocyanine compound; a source for irradiating the crystal with electromagnetic radiation; Equipped with In an X-ray diffraction pattern of a crystal of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak is present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the most intense peak within the range is 2.50° or less; Singlet oxygen is generated from the crystal. A singlet oxygen generating kit is provided.
[0011] According to another aspect of the present disclosure, Contains crystals of a phthalocyanine compound, In an X-ray diffraction pattern of a crystal of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak is present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the most intense peak within the range is 2.50° or less; A singlet oxygen generator is provided, which generates singlet oxygen by irradiating the crystal with electromagnetic radiation. Effect of the Invention
[0012] According to the present disclosure, it is possible to provide a singlet oxygen generating method, a singlet oxygen generating system, a singlet oxygen generating kit, and a singlet oxygen generator, which are capable of generating more singlet oxygen than ever before by irradiating a crystal of a phthalocyanine compound with electromagnetic radiation. Cut. [Brief description of the drawings]
[0013] [Figure 1] 1 is an X-ray diffraction pattern of a crystal of phthalocyanine compound 1 in an example. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0014] In the present disclosure, the description of "XX or more and YY or less" or "XX to YY" expressing a numerical range means a numerical range including the lower and upper limits, which are the endpoints, unless otherwise specified. When a numerical range is described in stages, the upper and lower limits of each numerical range can be arbitrarily combined. In addition, in the present disclosure, a description such as "at least one selected from the group consisting of XX, YY, and ZZ" means any of XX, YY, ZZ, a combination of XX and YY, a combination of XX and ZZ, a combination of YY and ZZ, or a combination of XX, YY, and ZZ.
[0015] The present disclosure provides a method for generating singlet oxygen, comprising: The generating method includes a step of generating singlet oxygen by irradiating a crystal of a phthalocyanine compound with electromagnetic radiation, In an X-ray diffraction pattern of the crystals of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak exists within a diffraction angle range of 2θ=5° to 35°, The present invention relates to a method for generating singlet oxygen, characterized in that the half-width of the most intense peak within the range is 2.50° or less.
[0016] According to the investigations of the present inventors, the above-mentioned configuration makes it possible to generate more singlet oxygen than a conventional phthalocyanine compound having no crystallinity. The details are explained below.
[0017] In order to increase the amount of singlet oxygen generated by irradiation with electromagnetic radiation, it is possible to approach increasing the permeability of the medium to electromagnetic radiation and increasing the amount of electromagnetic radiation that reaches the phthalocyanine compound. Another approach is to improve the sensitivity of the phthalocyanine compound to electromagnetic radiation. Specifically, for light, this can be done by expanding the conjugated ring to match the wavelength of the excitation light, and for X-rays, this can be done by increasing the mass absorption coefficient of heavy elements. As a more macroscopic and simple approach, there is a method of simply increasing the amount of phthalocyanine compound molecules present. However, there is a limit to how much the concentration of a single molecule can be increased, depending on the system. In that case, the amount of dye molecules present in the system can be dramatically increased by changing the phthalocyanine compound from a molecule to a more macroscopic particle state, in other words, by changing the dye from a dye to a pigment.
[0018] However, when the phthalocyanine compound is converted from a single molecule into a particle state, which is simply an aggregate of these molecules, the phthalocyanine compound located deep inside the particle and unable to come into contact with oxygen is unlikely to contribute to the production of singlet oxygen even if it is excited. Therefore, the present inventors attempted to increase the amount of singlet oxygen generated by efficiently transmitting triplet excitons generated in the deep phthalocyanine compound molecules that cannot come into contact with oxygen to the phthalocyanine compound molecules near the surface that can come into contact with oxygen. As a result of their investigation, they found that it is possible to improve the singlet oxygen generation efficiency by crystallizing the phthalocyanine compound molecules and suitably controlling the crystallinity. One aspect of the present disclosure will be specifically described below.
[0019] In the present disclosure, a phthalocyanine compound crystal is one in which, in an X-ray diffraction pattern obtained by X-ray diffraction using CuKα radiation, a peak is present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the most intense peak within said range is 2.50° or less. The half-width of the peak with the highest intensity is preferably 0.70° or less, and more preferably 0.50° or less. More preferred. In the present disclosure, the smaller the half-value width of the most intense peak in the diffraction angle range of 2θ=5° to 35° in an X-ray diffraction pattern, the higher the degree of crystallinity of the crystals of the phthalocyanine compound. A higher degree of crystallinity of the crystals of the phthalocyanine compound is preferable because it allows the propagation of triplet excitons to occur more effectively. For the same reason, in an X-ray diffraction pattern using CuKα radiation, the crystals of the phthalocyanine compound preferably have half-widths of the two most intense peaks within the range of 2θ=5° to 35° of 2.50° or less, more preferably 0.70° or less, and even more preferably 0.50° or less. The top two peaks with high intensity are thought to originate from the main diffraction planes specific to the crystal structure, such as the diffraction in the molecular axis direction perpendicular to the molecular stacking direction and the diffraction in the π-stack direction, etc. By measuring the half-widths of these peaks, the degree of crystallinity of the phthalocyanine compound crystals can be determined more accurately.
[0020] The lower limit of the half width is not particularly limited, and the smaller the better. It is preferably 0.20° or more, more preferably 0.10° or more, and even more preferably 0.05° or more. The half width is preferably 0.05 to 2.50°, 0.05 to 0.70°, or 0.05 to 0.50°.
[0021] The electromagnetic radiation preferably has a wavelength of 0.001 nm to 10 nm, since this facilitates excitation of the phthalocyanine compound deep inside the particles, more preferably has a wavelength of 0.001 nm to 2.5 nm, and particularly preferably has a wavelength of 0.001 nm to 1.5 nm. Specific examples of electromagnetic radiation having the above-mentioned preferred wavelengths include X-rays and gamma rays. The wavelength of the electromagnetic radiation can be measured by a semiconductor detector or the like.
[0022] The number-average particle size of the phthalocyanine compound crystals is preferably 30 nm or more, since the effect of crystallization is fully exhibited compared to amorphous state by ensuring a certain number of molecules. Even if the crystallinity is improved, the decay of triplet excitons cannot be completely eliminated, so the size of the whole particle is preferably 300 nm or less, and more preferably 200 nm or less. The number-average particle size of the phthalocyanine compound crystals can be appropriately adjusted by adjusting the output and processing time when dispersing the phthalocyanine compound crystals with an ultrasonic homogenizer or the like. The number average particle size is more preferably 30 nm or more and 200 nm or less, and further preferably 40 nm or more and 160 nm or less.
[0023] The number-average particle size of the phthalocyanine compound crystals can be measured by dynamic light scattering. In this disclosure, values measured using a dynamic light scattering particle size distribution analyzer Nanotrac UPA-EX150 (manufactured by Nikkiso Co., Ltd.) are used. Specifically, the range is set to 0.001 μm to 10 μm, and measurements are performed according to the following procedure. If the measurement sample is not dispersed in water, add the dispersion containing the measurement sample to an aqueous solution containing a surfactant, such as Family Fresh (manufactured by Kao Corporation), to prevent aggregation, and stir. After stirring, pour the measurement sample into the above device and measure twice to obtain the average value. The measurement conditions are as follows: measurement time is 30 seconds, the refractive index of the sample particles is 1.49, the dispersion medium is water, and the refractive index of the dispersion medium is 1.33.
[0024] Phthalocyanine compounds containing atoms with atomic numbers of 11 or more are sensitive to electromagnetic radiation. It is possible to improve the optical properties, and it is preferable that the atomic number is 13 or more. In addition, it may contain a plurality of types of atoms with atomic numbers of 11 or more. The types and number of types of atoms with atomic numbers of 11 or more are suitably selected from the viewpoints of the application, the electromagnetic radiation source, the contrast with the medium, and the like. The atom preferably has an atomic number of 11 or more and 85 or less, and more preferably has an atomic number of 13 or more and 85 or less. Specific examples of atoms with atomic numbers of 11 or more include at least one selected from the group consisting of Ga, Al, I, and Ti.
[0025] The phthalocyanine compound is preferably a metal phthalocyanine compound having a central metal atom from the viewpoint of sensitivity to electromagnetic radiation. The central metal atom is preferably an atom with an atomic number of 11 or more, since this makes it possible to improve the sensitivity to electromagnetic radiation, and more preferably an atom with an atomic number of 13 or more. The type of atom with an atomic number of 11 or more is suitably selected from the viewpoints of the application, the electromagnetic radiation source, the contrast with the medium, etc. The atom preferably has an atomic number of 11 or more and 85 or less, and more preferably has an atomic number of 13 or more and 85 or less. Specific examples of atoms with atomic numbers of 11 or more include at least one selected from the group consisting of Ga, Al, and Ti. More preferably, the crystal of the phthalocyanine compound is a crystal of a gallium phthalocyanine compound or a titanyl phthalocyanine compound.
[0026] It is preferable for the metal phthalocyanine compound to have an axial ligand from the viewpoint of controlling crystallinity. It is preferable that the axial ligand of the metal phthalocyanine compound is a halogen atom or a hydroxyl group from the viewpoints of controlling crystallinity and improving sensitivity to electromagnetic radiation. The halogen atom is, for example, fluorine, chlorine, bromine or iodine.
[0027] It is preferable that the crystal of the metal phthalocyanine compound is a crystal of hydroxygallium phthalocyanine, since the propagation of triplet excitons occurs more effectively. Phthalocyanine molecules are generally known to have a planar shape, with their π orbitals extending in a direction perpendicular to the molecular plane (the molecular axis direction). Therefore, the phthalocyanine crystal has a columnar structure in which faces are stacked against each other due to intermolecular interactions of the π bonding nature of the planar molecules. Therefore, many phthalocyanine crystals, particularly type V hydroxygallium phthalocyanine crystals, have characteristic X-ray diffraction patterns. The peak at a diffraction angle of 2θ = 7.4° ± 0.3° in the X-ray diffraction pattern using CuKα radiation is thought to be due to diffraction from the (0,1,0) plane based on the results of Rietveld crystal structure analysis, and it has been elucidated that this is a diffraction plane in the direction of the molecular axis. Similarly, the peak at 28.2°±0.3° is thought to be due to diffraction from the (2,-1,-2) plane, which has been elucidated to be a diffraction plane in the π-stack direction. From these peaks at the diffraction angle 2θ, it is possible to identify the crystal structure of the phthalocyanine compound.
[0028] The elemental species of the metal atom, central metal atom, and axial ligand in the phthalocyanine compound crystal can be identified, for example, by fluorescent X-ray analysis. Specifically, the measurement device is a wavelength dispersive X-ray fluorescence analyzer "Axios" (manufactured by PANalytical) and the accompanying dedicated software "SuperQ ver.4.0F" for setting measurement conditions and analyzing measurement data. (PANalytical) is used. The anode of the X-ray tube is Rh, the measurement atmosphere is vacuum, the measurement diameter (collimator mask diameter) is 27 mm, and the measurement time is 10 seconds. A known detector such as a proportional counter (PC) or a scintillation counter (SC) is used as the detector. Whether the detected metal atom species is the central metal atom is judged by comparing the absorption spectrum with a database of existing metal phthalocyanines, etc. The measurement device used is a V-560 manufactured by JASCO Corporation, etc. In addition, whether the detected nonmetallic atoms with atomic numbers of 11 or more are axial ligands or bond by replacing hydrogen on the phthalocyanine ring, 1 This is judged by whether a decrease in the amount of hydrogen in the phthalocyanine ring is observed by H-NMR measurement.
[0029] The X-ray diffraction pattern of the crystals of the phthalocyanine compound using CuKα radiation can be obtained by X-ray diffraction measurement. Specifically, X-ray diffraction measurements are performed using the following equipment and conditions. Measuring equipment used: Rigaku Electric Co., Ltd., X-ray diffraction device RINT-TTRII X-ray tube:Cu X-ray wavelength: 0.15418nm Spectral line: Kα1 Tube voltage: 50KV Tube current: 300mA Scan method: 2θ scan Scan speed: 4.0° / min Sampling interval: 0.02° Start angle 2θ: 5.0° Stop angle 2θ: 35.0° Goniometer: Rotor horizontal goniometer (TTR-2) Attachment: Capillary rotating sample stage Filter: None Detector: Scintillation counter Incident Monochrome: Use Slit: Variable slit (parallel beam method) Counter monochromator: Not used Divergence slit: open Divergence vertical limit slit: 10.00mm Scattering slit: open Receiving slit: open
[0030] The phthalocyanine crystal preferably contains a compound represented by the following formula (1), because the charge trap sites are offset by the intramolecular polarity of the compound, resulting in effective propagation of triplet excitons and an increase in the amount of singlet oxygen generated. [ka] (In formula (1), X 1 represents a hydrogen atom, a methyl group, or an ethyl group; X 2 represents a hydrogen atom, a methyl group, or an ethyl group. A specific example of the compound represented by formula (1) is at least one selected from the group consisting of N-methylformamide and N,N-dimethylformamide.
[0031] In addition, among the compounds represented by formula (1), X 2 is preferably a hydrogen atom, that is, a compound represented by the following formula (2). [ka] (In formula (2), X 1 represents a hydrogen atom, a methyl group, or an ethyl group. A specific example of the compound represented by formula (2) is N-methylformamide.
[0032] From the viewpoint of the above-mentioned effects, the content of the compound represented by the formula (1) in the phthalocyanine crystal is preferably from 0.10% by mass to 1.70% by mass, more preferably from 0.20% by mass to 1.20% by mass. The content of the compound represented by the formula (1) can be adjusted by the treatment time in the crystal conversion step described below. The content of the compound represented by the formula (1) tends to increase when the treatment time is shortened.
[0033] The crystals of the phthalocyan compound will be specifically described below. The phthalocyanine compound is not particularly limited, and one or more of known phthalocyanine compounds can be used in addition to phthalocyanine. Examples of metal phthalocyanines that coordinate to an element having an atomic number of 11 or more include aluminum phthalocyanine, silicon phthalocyanine, titanyl phthalocyanine, vanadium phthalocyanine, chromium phthalocyanine, manganese phthalocyanine, iron phthalocyanine, cobalt phthalocyanine, nickel phthalocyanine, copper phthalocyanine, zinc phthalocyanine, gallium phthalocyanine, germanium phthalocyanine, zirconium phthalocyanine, niobium phthalocyanine, molybdenum phthalocyanine, rhodium phthalocyanine, palladium phthalocyanine, silver phthalocyanine, cadmium phthalocyanine, indium phthalocyanine, tin phthalocyanine, barium phthalocyanine, hafnium phthalocyanine, tungsten phthalocyanine, iridium phthalocyanine, platinum phthalocyanine, gold phthalocyanine, mercury phthalocyanine, lead phthalocyanine, and europium phthalocyanine.
[0034] The metal phthalocyanine may have an axial ligand, such as a halogen atom, a hydroxyl group, an optionally substituted alkoxy group, a derivative of a compound having an alkoxy group, an optionally substituted silanolate group, or a derivative of a compound having a silanolate group. Examples of metal phthalocyanines having a halogen atom as an axial ligand include chlorometal phthalocyanine crystals, bromometal phthalocyanine crystals, and iodometal phthalocyanine crystals. In particular, iodometal phthalocyanine crystals are preferred from the viewpoint of sensitivity to electromagnetic radiation. Chlorometal phthalocyanine crystals have chlorine atoms as axial ligands, bromometal phthalocyanine crystals have bromine atoms as axial ligands, and iodophthalocyanine crystals have iodine atoms as axial ligands. In order to obtain a hydroxymetal phthalocyanine having a hydroxy group as an axial ligand, for example, a halogenated phthalocyanine is dissolved in concentrated sulfuric acid to liberate the halogen, and then the solution is treated with aqueous ammonia.
[0035] These metal phthalocyanine compounds having a halogen atom as an axial ligand can be obtained through a treatment step in which a hydroxy metal phthalocyanine is mixed with an aqueous solution of hydrochloric acid, bromic acid, iodic acid or the like having the halogen atom. In these treatment steps, hydrochloric acid, bromic acid, iodine, etc. are mixed with the hydroxy metal phthalocyanine. The concentration of the aqueous solution of uric acid or the like is preferably 10% by mass or more, more preferably 30% by mass or more, from the viewpoint of reactivity. The mixing step of the aqueous solution of hydrochloric acid, bromic acid, iodic acid or the like to be mixed with the hydroxy metal phthalocyanine can be performed by milling or stirring. Furthermore, for example, the phthalocyanine compound loses the axial ligand when treated with a strong acid such as concentrated sulfuric acid.
[0036] Also usable are substituted phthalocyanines in which a part of the phthalocyanine ring of phthalocyanine and metal phthalocyanine is substituted.Specific examples of the substituent include at least one selected from the group consisting of halogens such as chlorine, bromine, and iodine, hydroxyl groups, amino groups, imino groups, cyano groups, nitro groups, sulfo groups, optionally substituted alkyl groups, alkenyl groups, alkynyl groups, aryl groups, arylalkyl groups, heteroaryl groups, alkoxy groups, alkenyloxy groups, alkynyloxy groups, aryloxy groups, heteroaryloxy groups, acyl groups, acetyl groups, formyl groups, carboxy groups, and carbonyl groups.
[0037] The crystals of the phthalocyanine compound can be obtained in a crystal conversion step in which a conversion solvent, for example, a compound represented by formula (1), is added to the phthalocyanine compound and milled to convert the crystals of the phthalocyanine compound. By performing milling using a conversion solvent containing the compound represented by formula (1) as the conversion solvent, the compound represented by formula (1) can be contained in the crystals of the phthalocyanine compound. The milling treatment here is a treatment carried out using a milling device such as a sand mill or a ball mill together with a dispersant such as glass beads, steel beads, alumina balls, etc. The amount of the compound represented by the formula (1) added in the milling treatment is preferably 5 to 30 times the amount of the phthalocyanine compound on a mass basis.
[0038] In addition to the compound represented by the above formula (1), the conversion solvent may be, for example, an amide solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, or 1-methyl-2-pyrrolidone, a halogen solvent such as chloroform, an ether solvent such as tetrahydrofuran, or a sulfoxide solvent such as dimethyl sulfoxide. The amount of the solvent used is preferably 5 to 30 times the amount of the phthalocyanine compound on a mass basis. If the amount of conversion solvent used is too large, the concentration will be low, which will reduce the processing efficiency during milling and will tend to make it difficult to increase the crystallinity of the phthalocyanine compound.On the other hand, if the amount of conversion solvent used is too small and too concentrated, the processing efficiency will increase too much, and the physical impact will be too strong, which will destroy the crystals themselves and tend to reduce the crystallinity.
[0039] The milling time is preferably 4 hours or more, more preferably 200 hours or more, and even more preferably 200 hours or more and 2000 hours or less. By appropriately selecting the type and amount of the conversion solvent, and the milling time, the crystallinity of the phthalocyanine compound can be adjusted.
[0040] <Quantitative method for the compound represented by formula (1), NMR> The obtained crystals of the phthalocyanine compound were examined to see whether they contained the conversion solvent, particularly the compound represented by the formula (1), in the crystals. 1 It is determined by H-NMR measurement and data analysis. Specifically, the presence or absence of a peak derived from the compound represented by formula (1) among the measured peaks of the phthalocyanine compound and the content thereof are quantified from the area of the peak. The NMR measurement of the crystal of the phthalocyanine compound is carried out under the following conditions. [ 1 H-NMR measurement] Measuring instrument used: BRUKER, product name: AVANCEIII 500 Solvent: Bisulfuric acid (D2SO4) Accumulation count: 2000
[0041] <How to generate singlet oxygen> Specific examples of the method for generating singlet oxygen by irradiating a crystal of a phthalocyanine compound according to the present disclosure with electromagnetic radiation include, but are not limited to, the following steps (I) and (II): Step (I): A step of placing crystals of a phthalocyanine compound in an atmosphere containing oxygen. Step (II): A step of irradiating the crystals of the phthalocyanine compound placed in step (I) with electromagnetic radiation. In step (I), the method of placing the crystals in an oxygen-containing atmosphere is not particularly limited as long as the crystals are brought into contact with oxygen. For example, the crystals of the phthalocyanine compound are placed in an air atmosphere, and the crystals are coated for dispersion in water as described below, dispersed in water, and then mixed with a liquid containing oxygen gas dissolved therein. It is preferable to disperse the crystals of the phthalocyanine compound in a liquid containing water containing oxygen. When crystals of a phthalocyanine compound are dispersed in a liquid containing water, the concentration is not particularly limited, and may be 0.0001% by mass to 50% by mass, or 0.001% by mass to 20% by mass.
[0042] In step (II), the method of irradiating electromagnetic radiation is not particularly limited as long as electromagnetic radiation of sufficient intensity is irradiated to generate singlet oxygen. Specifically, it is most preferable to use an electromagnetic radiation irradiating device and perform the irradiation in a vacuum where no substance exists between the crystal of the phthalocyanine compound in theory from the viewpoint of suppressing attenuation and scattering of electromagnetic radiation, but in practice, it is preferable to perform the irradiation in the air, water, or other medium under conditions where there is as little as possible of an absorber of electromagnetic radiation between the crystal and the phthalocyanine compound. The integrated light amount of the electromagnetic radiation is preferably 0.01 Gy to 1000 Gy, and more preferably 0.1 Gy to 100 Gy. The irradiation time is not particularly limited and is appropriately set depending on the device used, the amount of singlet oxygen to be generated, and the like. The distance between the crystal of the phthalocyanine compound and the source of electromagnetic radiation is not particularly limited, but is suitably set depending on the degree of absorption and scattering of electromagnetic radiation by the material existing between the irradiation device and the crystal of the phthalocyanine compound.
[0043] <Coating method for dispersion in water> The crystal of the phthalocyanine compound may have a coating layer of a compound having a suitable function on the surface depending on the application. The compound on the surface may be chemically or electrostatically bonded to the crystal surface of the phthalocyanine compound. The compound may also be introduced as a substituent of the phthalocyanine ring. The compound may also be introduced as an axial ligand of the phthalocyanine compound molecule on the surface. Alternatively, the compound may be encapsulated in a micelle of an amphiphilic molecule.
[0044] For example, in applications requiring dispersibility in water or hydrophilicity, the crystal surface of the phthalocyanine compound can be coated with a compound having at least one of hydrogen bonds or a site capable of forming a hydration layer, or these sites can be substituted or introduced into the phthalocyanine compound.Specific examples of such compounds include compounds having a hydroxy group, an amide bond, an ethylene oxide, a betaine structure, a phosphate ester, etc. As a specific form of coating, for example, the crystal surface of the phthalocyanine compound can be coated and polymerized with a monomer containing glycidyl methacrylate, and then a monomer having a hydroxyl group such as 3-mercapto-1,2-propanediol can be ring-opening polymerized to the epoxy ring derived from the glycidyl methacrylate to introduce a hydroxyl group onto the surface. It is also possible to introduce a hydroxyl group into the phthalocyanine ring of the phthalocyanine compound on the crystal surface. Hydrophilic ligands such as (sulfopropyl)(3-sulfonatopropyl)azaniumyl)propyl}dimethylsilanolate can also be introduced.
[0045] In applications requiring dispersibility in water, the phthalocyanine compound can be coated with a compound having a site that generates electrostatic repulsion, or the phthalocyanine compound can be substituted or introduced with such a site. Examples of the site that generates electrostatic repulsion include a carboxyl group, a sulfonic acid group, an amino group, and an imino group.
[0046] The surfactant may also be encapsulated in a micelle such as a surfactant. Specific examples of the surfactant include cetyltrimethylammonium chloride, tetramethylammonium chloride, tetrabutylammonium chloride, dodecyldimethylbenzylammonium chloride, alkyltrimethylammonium chloride, octyltrimethylammonium chloride, hexadecyltrimethylammonium chloride, cetyltrimethylammonium bromide, alkyltrimethylammonium bromide, hexadecyltrimethylammonium bromide, benzalkonium bromide, sodium dodecyl sulfate, sodium lauryl sulfate, tetraethylene glycol monododecyl ether, pentaethylene glycol monododecyl ether, octaethylene glycol monododecyl ether, Newcol (registered trademark) (manufactured by Nippon Nyukazai Co., Ltd.), and Emulgen (registered trademark) (manufactured by Kao Corporation).
[0047] In addition, for example, in applications requiring biocompatibility, the surface of the crystal of the phthalocyanine compound may be coated with at least one molecule selected from the group consisting of hydrophilic polymers such as polyethylene glycol, polyvinylpyrrolidine, polyvinyl methyl ether, polymethyloxazoline, polyethyloxazoline, polyhydroxy-propyloxazoline, polyhydroxypropyl methacrylamide, polymethacrylamide, polydimethylacrylamide, polyhydroxypropyl methacrylate, polyhydroxy-ethyl acrylate, hydroxymethyl cellulose, hydroxyethyl cellulose, and polyethylene-imine, which are covalently or electrostatically bonded, and lipids such as 1,2-dioleoyl-3-trimethylammonium propane (DOTAP), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)] (DSPE-PEG). Other known biocompatible molecules can be used. They may also be encapsulated in micelles of these molecules.
[0048] <Quantitative analysis of singlet oxygen> The amount of singlet oxygen generated when a crystal of a phthalocyanine compound is irradiated with electromagnetic radiation is quantified using an aqueous solution of 4-nitroso-N,N-dimethylaniline. When singlet oxygen is generated by irradiating electromagnetic radiation to crystals of a phthalocyanine compound dispersed in an aqueous solution of 4-nitroso-N,N-dimethylaniline containing histidine, the singlet oxygen reacts with 4-nitroso-N,N-dimethylaniline, and the absorbance at 440 nm in the UV-visible spectrum originating from 4-nitroso-N,N-dimethylaniline decreases. This change in absorbance correlates with the amount of singlet oxygen generated, making quantitative measurement and comparison possible. The equipment and measurement conditions used are as follows: Measurement solution: 4-nitroso-N,N-dimethylaniline 25 μM, histidine 10 mM Measuring instrument used: Ultraviolet-visible spectrophotometer JASCO V-570 manufactured by JASCO Corporation. Photometric mode: Abs absorbance measurement Response: fast Bandwidth: 2.0nm Scanning speed: 200nm / min Data capture interval: 0.5 nm
[0049] <Singlet oxygen generation system, kit> The above-mentioned method for generating singlet oxygen can be carried out using a singlet oxygen generating system including a crystal of a phthalocyanine compound and an apparatus having a source for irradiating the crystal with electromagnetic radiation. Furthermore, the phthalocyanine compound crystals may be provided in the form of a singlet oxygen generating kit in which components such as a radiation source for irradiating the crystals with electromagnetic radiation are combined. The preferred embodiment of the crystal of the phthalocyanine compound is the same as that of the method for generating singlet oxygen described above. The device having a radiation source for irradiating electromagnetic radiation is not particularly limited as long as it can perform the step (II) in the above-mentioned method for generating singlet oxygen. For example, a crystal of a phthalocyanine compound can be placed at the irradiation destination of a radiation source known as an X-ray tube, a linac, a synchrotron radiation irradiation device from other accelerators, or a device having a radioisotope, to form a system or kit. It is preferable that a vacuum is maintained between the radiation source and the crystals of the phthalocyanine compound, but air, water, or other media may be present, and it is preferable that at least substances that absorb electromagnetic radiation, such as lead, are absent as much as possible.
[0050] <Singlet oxygen generator> The crystal of the phthalocyanine compound can be used as a singlet oxygen generator. The preferred embodiment of the crystal of the phthalocyanine compound is the same as that of the method for generating singlet oxygen described above. The method for formulating the crystals of the phthalocyanine compound as a singlet oxygen generator is not particularly limited as long as the singlet oxygen generator contains the crystals of the phthalocyanine compound. The content of the crystals of the phthalocyanine compound in the singlet oxygen generator is preferably 0.0001% by mass to 50% by mass, and more preferably 0.001% by mass to 20% by mass.
[0051] The singlet oxygen generator may be in a solid or liquid form. The singlet oxygen generator may contain, for example, an excipient, a lubricant, a binder, and a disintegrant in a solid preparation, or a solvent, a solubilizing agent, a suspending agent, an isotonicity agent, a buffer, etc. in a liquid preparation. If necessary, the singlet oxygen generator may further contain appropriate amounts of additives such as a preservative, an antioxidant, a coloring agent, an adsorbent, and a wetting agent.
[0052] The crystals of the phthalocyanine compound in the singlet oxygen generator may be dispersed in a medium such as water in the form of nanoparticles, or may be fixed to the surface of a carrier.The carrier may be a bulk solid phase, or may be another nanoscale particle, microscale particle, liposome, or other particle.It may also be physically contained in a gel-like polymer such as hyaluronic acid. The surface of the crystal of the phthalocyanine compound may have a coating layer for the purpose of improving the medium dispersibility or stability, or may be encapsulated in a micelle, etc. Furthermore, a molecule having another function, such as a molecule corresponding to a ligand having a targeting function in vivo, may be bonded or added. EXAMPLES
[0053] The present invention will be described in more detail below with reference to specific examples. However, the present invention is not limited to these. In the following, "parts" refers to "parts by mass."
[0054] <Method for Producing Crystals of Phthalocyanine Compound 1> In a nitrogen flow atmosphere, 5.46 parts of orthophthalonitrile and 45 parts of α-chloronaphthalene were put into a reaction vessel, which was then heated to a temperature of 30° C. and maintained at this temperature. Next, 3.75 parts of gallium trichloride were put in at this temperature (30° C.). The water concentration of the mixed liquid at the time of the addition was 150 ppm. The temperature was then raised to 200° C. Next, the mixture was heated under nitrogen flow. After reacting for 4.5 hours at 200°C under an atmosphere of 100°C, the mixture was cooled, and when the temperature reached 150°C, the product was filtered. The resulting filtered material was dispersed and washed using N,N-dimethylformamide at 140°C for 2 hours, and then filtered. The resulting filtered material was washed with methanol and dried to obtain chlorogallium phthalocyanine.
[0055] 4.65 parts of the obtained chlorogallium phthalocyanine was dissolved in 139.5 parts of concentrated sulfuric acid at a temperature of 10°C, dropped into 620 parts of ice water under stirring to reprecipitate, and filtered under reduced pressure using a filter press. No. 5C (manufactured by Advantec Co., Ltd.) was used as the filter. The obtained wet cake (filtrate) was dispersed and washed with 2% ammonia water for 30 minutes, and then filtered using a filter press. Next, the obtained wet cake (filtrate) was dispersed and washed with ion-exchanged water, and then filtration using a filter press was repeated three times. Finally, freeze-drying (lyophilization) was performed to obtain hydroxygallium phthalocyanine.
[0056] 0.5 parts of the obtained hydroxygallium phthalocyanine and 9.5 parts of N-methylformamide (product code: F0059, manufactured by Tokyo Chemical Industry Co., Ltd.), which is a compound represented by formula (1) as a conversion solvent, were milled in a ball mill together with 15 parts of glass beads having a diameter of 0.8 mm at room temperature (23°C) for 600 hours. At this time, a standard bottle (product code: PS-6, manufactured by Kashiwa Glass Co., Ltd.) was used as the container, and the milling was performed under the condition that the container rotated 60 times per minute. Gallium phthalocyanine crystals were taken out from this dispersion using tetrahydrofuran, filtered, and the top of the filter was thoroughly washed with tetrahydrofuran. The filtered product was dried in a vacuum to obtain 0.45 parts of crystals of phthalocyanine compound 1.
[0057] The X-ray diffraction pattern of the obtained crystals is shown in Figure 1. It can be seen that there are peaks in CuKα X-ray diffraction at diffraction angles 2θ = 7.4° ± 0.2° and 28.3° ± 0.2°. The half-widths of the top two peaks with high intensity in the X-ray diffraction pattern of CuKα rays are shown in Table 1.
[0058] The crystals were dissolved in bisulfuric acid. 1When H-NMR measurement was performed, a peak derived from N-methylformamide was observed in addition to the peak derived from the molecules of phthalocyanine compound 1. Since N-methylformamide is a liquid at room temperature and is compatible with tetrahydrofuran, it is understood that N-methylformamide is contained in the crystals of phthalocyanine compound 1. The content of N-methylformamide in the crystals of phthalocyanine compound 1 was 0.9 mass% calculated from the proton ratio. The presence or absence of metal atoms with atomic numbers of 11 or more in the obtained crystals, the type of central metal atom, and the type of axial ligand were determined by X-ray fluorescence analysis and absorption spectroscopy. 1 A comprehensive evaluation was made using H-NMR measurements, and the results are shown in Table 1.
[0059] <Method for Producing Crystals of Phthalocyanine Compound 2> Crystals of phthalocyanine compound 2 were obtained in the same manner as in the method for producing crystals of phthalocyanine compound 1, except that the milling treatment was performed for 200 hours. Table 1 shows the half-widths of the two most intense peaks in the CuKα X-ray diffraction pattern of the obtained crystals of phthalocyanine compound 2, the type and content of the compound represented by formula (1), the presence or absence of metal atoms with atomic numbers of 11 or more, the type of central metal atom, and the type of axial ligand.
[0060] <Method for Producing Crystals of Phthalocyanine Compound 3> Crystals of phthalocyanine compound 3 were obtained in the same manner as in the method for producing crystals of phthalocyanine compound 1, except that the milling treatment was performed for 1000 hours. Table 1 shows the half-widths of the two most intense peaks in the X-ray diffraction pattern of CuKα rays for the obtained crystals of phthalocyanine compound 3, the type and content of the compound represented by formula (1), the presence or absence of metal atoms with atomic numbers of 11 or more, the type of central metal atom, and the type of axial ligand.
[0061] <Method for Producing Crystals of Phthalocyanine Compound 4> Crystals of phthalocyanine compound 4 were obtained in the same manner as in the method for producing crystals of phthalocyanine compound 1, except that the conversion solvent N-methylformamide was changed to N,N-dimethylformamide (product code: D0722, manufactured by Tokyo Chemical Industry Co., Ltd.). Table 1 shows the half-width of the top two peaks with high intensity in the X-ray diffraction pattern of CuKα line for the obtained crystals of phthalocyanine compound 4, the type and content of the compound represented by formula (1), the presence or absence of metal atoms with atomic numbers of 11 or more, the type of central metal atom, and the type of axial ligand.
[0062] <Method for Producing Crystals of Phthalocyanine Compound 5> 10 parts of crystals of phthalocyanine compound 1 and 200 parts of iodic acid with a concentration of 35% by mass and a temperature of 23°C were mixed and stirred with a magnetic stirrer for 90 minutes. The amount of iodic acid mixed was 118 mol of hydrogen iodide with respect to 11 mol of phthalocyanine compound. After stirring, the mixture was dropped into 1,000 parts of ion-exchanged water cooled with ice water and stirred with a magnetic stirrer for 30 minutes. This was filtered under reduced pressure. At this time, No. 5C (manufactured by Advantec Co., Ltd.) was used as the filter. Then, dispersion washing was performed four times with ion-exchanged water at a temperature of 23°C. In this way, 9 parts of crystals of phthalocyanine compound 5 were obtained. Table 1 shows the half-width of the top two peaks with high intensity in the X-ray diffraction pattern of CuKα rays of the obtained crystals of phthalocyanine compound 5, the type and content of the compound represented by formula (1), the presence or absence of metal atoms with atomic numbers of 11 or more, the central metal atom species, and the axial ligand species.
[0063] <Method for Producing Crystals of Phthalocyanine Compound 6> Crystals of phthalocyanine compound 6 were obtained in the same manner as in the production method for crystals of phthalocyanine compound 4, except that 3.75 parts of gallium trichloride was changed to 2.84 parts of aluminum chloride. Table 1 shows the half-widths of the two most intense peaks in the X-ray diffraction pattern of CuKα rays for the obtained crystals of phthalocyanine compound 6, the type and content of the compound represented by formula (1), the presence or absence of metal atoms with atomic numbers of 11 or more, the type of central metal atom, and the type of axial ligand.
[0064] <Method for producing crystals of phthalocyanine compound 7> Crystals of phthalocyanine compound 7 were obtained in the same manner as in the method for producing crystals of phthalocyanine compound 4, except that the conversion solvent, N,N-dimethylformamide, was changed to tetrahydrofuran. Table 1 shows the half-widths of the two most intense peaks in the X-ray diffraction pattern of CuKα rays for the obtained crystals of phthalocyanine compound 7, the type and content of the compound represented by formula (1), the presence or absence of metal atoms with atomic numbers of 11 or more, the type of central metal atom, and the type of axial ligand.
[0065] <Method for producing crystals of phthalocyanine compound 8> Crystals of phthalocyanine compound 8 were obtained in the same manner as in the method for producing crystals of phthalocyanine compound 7, except that the milling treatment time was changed to 300 hours. Table 1 shows the half-width of the top two peaks with high intensity in the X-ray diffraction pattern of CuKα line for the obtained crystals of phthalocyanine compound 8, the type and content of the compound represented by formula (1), the presence or absence of metal atoms with atomic numbers of 11 or more, the type of central metal atom, and the type of axial ligand.
[0066] <Method for producing crystals of phthalocyanine compound 9> In a nitrogen flow atmosphere, 5.46 parts of orthophthalonitrile and 45 parts of α-chloronaphthalene were put into a reaction vessel, and then heated to a temperature of 30°C and maintained at this temperature. Next, 3.75 parts of copper dichloride were put in at this temperature (30°C). The water concentration of the mixed liquid at the time of putting in was 150 ppm. Then, the temperature was raised to 200°C. Next, under a nitrogen flow atmosphere, the reaction was carried out at a temperature of 200°C for 4.5 hours, and then cooled. When the temperature reached 150°C, the product was filtered. The obtained filtrate was dispersed and washed using N,N-dimethylformamide at a temperature of 140°C for 2 hours, and then filtered. The obtained filtrate was washed with methanol and then dried to obtain copper phthalocyanine. 4.65 parts of the obtained copper phthalocyanine was dissolved in 139.5 parts of concentrated sulfuric acid at a temperature of 10°C, dropped into 620 parts of ice water under stirring to reprecipitate, and filtered under reduced pressure using a filter press. At this time, No. 5C (manufactured by Advantec Co., Ltd.) was used as the filter. The obtained wet cake (filtrate) was dispersed and washed with ion-exchanged water for 30 minutes, and then filtered using a filter press. Next, the obtained wet cake (filtrate) was dispersed and washed with ion-exchanged water, and then filtration using a filter press was repeated three times. Finally, freeze-drying was performed to obtain crystals of phthalocyanine compound 9. Table 1 shows the half-width of the top two peaks with high intensity in the X-ray diffraction pattern of CuKα rays of the obtained crystals of phthalocyanine compound 9, the type and content of the compound represented by formula (1), the presence or absence of metal atoms with atomic numbers of 11 or more, the central metal atom species, and the axial ligand species.
[0067] <Method for Producing Crystals of Phthalocyanine Compound 10> 100 parts of α-chloronaphthalene, 5.0 parts of o-phthalodinitrile, and 2.0 parts of titanium tetrachloride were heated and stirred at 200°C for 3 hours, then cooled to 50°C and the precipitated crystals were filtered off to obtain a paste of dichlorotitanium phthalocyanine. This was then washed with stirring in N,N-dimethylformamide heated to 100°C, and then washed twice with methanol at 60°C and filtered off. The resulting paste was further stirred in deionized water at 80°C for 1 hour and filtered off to obtain 4.3 parts of titanyl phthalocyanine. 0.5 parts of the titanyl phthalocyanine obtained, 10 parts of tetrahydrofuran, and 15 parts of glass beads with a diameter of 0.9 mm were milled for 3 hours at room temperature (23°C) using a paint shaker (manufactured by Toyo Seiki Seisakusho) (first stage). At this time, a standard bottle (product name: PS-6, manufactured by Kashiwa Glass) was used as the container. The liquid thus milled was filtered through a filter (product number: N-NO.125T, pore size: 133 μm, manufactured by NBC Meshtec) to remove the glass beads. This liquid was milled for 300 hours at room temperature (23°C) using a ball mill (second stage). At this time, a standard bottle (product name: PS-6, manufactured by Kashiwa Glass) was used as the container, and the milling was performed under the condition of 120 rotations per minute. 30 parts of tetrahydrofuran was added to the treated liquid, and then the liquid was filtered and washed. The washed filtered product was then vacuum dried to obtain 0.44 parts of phthalocyanine compound crystals 10. Table 1 shows the half-width of the two most intense peaks in the CuKα X-ray diffraction pattern of the obtained crystals of phthalocyanine compound 10, the type and content of the compound represented by formula (1), the presence or absence of metal atoms with atomic numbers of 11 or more, the type of central metal atom, and the type of axial ligand.
[0068] <Method for producing crystals of phthalocyanine compound 11> Under a nitrogen flow atmosphere, 5.46 parts of orthophthalonitrile and 45 parts of amyl alcohol were put into a reaction vessel, and then 7.23 parts of 1,8-diazabicyclo[5,4,0]undecene-7 were added using a dropping funnel, and the mixture was heated to reflux for 5 hours. The temperature was then raised to 200°C. Next, the mixture was reacted at 200°C for 4.5 hours under a nitrogen flow atmosphere, cooled, and the product was filtered when the temperature reached 150°C. The resulting filtrate was dispersed and washed using N,N-dimethylformamide at 140°C for 2 hours, and then filtered. The resulting filtrate was washed with methanol and dried to obtain crystals of phthalocyanine compound 11. Table 1 shows the half-width of the top two peaks with high intensity in the X-ray diffraction pattern of CuKα rays of the obtained crystals of phthalocyanine compound 11, the type and content of the compound represented by formula (1), the presence or absence of metal atoms with atomic numbers of 11 or more, the central metal atom type, and the axial ligand type.
[0069] <Method of producing phthalocyanine compound 12> 4.65 parts of crystals of phthalocyanine compound 11 were dissolved in 139.5 parts of concentrated sulfuric acid at a temperature of 10°C, and reprecipitated by dropping into 620 parts of ice water under stirring, and filtered under reduced pressure using a filter press. No. 5C (manufactured by Advantec Co., Ltd.) was used as the filter. The obtained wet cake (filtrate) was dispersed and washed with 2% ammonia water for 30 minutes, and then filtered using a filter press. Next, the obtained wet cake (filtrate) was washed with ionized water. After dispersion and washing with exchanged water, filtration using a filter press was repeated three times. Finally, freeze-drying was performed to obtain phthalocyanine compound 12. Table 1 shows the half-width of the top two peaks with high intensity in the X-ray diffraction pattern of CuKα line for the obtained phthalocyanine compound 12, the type and content of the compound represented by formula (1), the presence or absence of metal atoms with atomic numbers of 11 or more, the type of central metal atom, and the type of axial ligand.
[0070] [Table 1]
[0071] <Example 1> The obtained crystals of phthalocyanine compound 1 were dispersed in a 0.1 mg / mL aqueous solution of a surfactant (Emulgen manufactured by Kao Corporation) to a concentration of 1 mg / mL, and treated with an ultrasonic homogenizer (VCX-750 manufactured by Sonics & Materials Co., Ltd.) at an output of 100 kW for 30 seconds to obtain a dispersion of crystals of phthalocyanine compound 1. The number-average particle size of the crystals of phthalocyanine compound 1 was 149.2 nm.
[0072] [Evaluation of the effect of enhancing the amount of singlet oxygen generated] The absorbance at 440 nm in the UV-visible spectrum of an aqueous solution of 25 μM 4-nitroso-N,N-dimethylaniline and 10 mM histidine was measured using a spectrophotometer. Next, this aqueous solution was irradiated for 10 seconds with mixed X-rays (white X-rays) containing electromagnetic radiation with wavelengths between 0.001 nm and 10 nm, which is emitted when a tube voltage of 60 kV and 30 mA is applied to an X-ray tube with a tungsten target anode and a beryllium transmission window, and the absorbance at 440 nm in the UV-visible spectrum was measured in the same manner. The rate of decrease Rr in the absorbance at 440 nm was calculated from the UV-visible spectra before and after irradiation. Next, 5 ml of the dispersion of the crystals of the phthalocyanine compound 1 was mixed with 5 ml of an aqueous solution of 50 μM 4-nitroso-N,N-dimethylaniline and 20 mM histidine, and the absorbance at 440 nm in the UV-visible spectrum was measured with a spectrophotometer. Next, the mixture was irradiated with the same white X-ray for 10 seconds, and the absorbance at 440 nm in the UV-visible spectrum was measured in the same manner, and the reduction rate Rx of the absorbance at 440 nm in the UV-visible spectrum before and after irradiation was calculated. Furthermore, the enhancement effect Ege of the amount of singlet oxygen generated by the crystals of phthalocyanine compound 1 was calculated from the following formula. Ege = (Rx-Rr) / Rr The obtained Ege is shown in Table 2.
[0073] <Examples 2 to 14, Comparative Example 1> In Example 1, the crystals of phthalocyanine compound 1 were changed to crystals of phthalocyanine compounds 2 to 11 and phthalocyanine compound 12 as shown in Table 2, respectively, and the crystals were homogenized by an ultrasonic homogenizer. The effect of enhancing the amount of singlet oxygen generated was evaluated in the same manner, except that the output and processing time of the laser were changed as shown in Table 2. The number-average particle size of the phthalocyanine compound and the enhancement effect Ege of the amount of singlet oxygen generated are shown in Table 2.
[0074] [Table 2] In Table 2, Pc compound refers to a phthalocyanine compound.
[0075] The present disclosure relates to the following configurations. (Configuration 1) A method for generating singlet oxygen, comprising the steps of: The generating method includes a step of generating singlet oxygen by irradiating a crystal of a phthalocyanine compound with electromagnetic radiation, In an X-ray diffraction pattern of the crystals of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak exists within a diffraction angle range of 2θ=5° to 35°, A method for generating singlet oxygen, characterized in that the half-width of the most intense peak within the range is 2.50° or less. (Configuration 2) 2. The method for generating singlet oxygen according to claim 1, wherein the wavelength of the electromagnetic radiation is 0.001 nm or more and 10 nm or less. (Configuration 3) 3. The method for generating singlet oxygen according to claim 1 or 2, wherein the number-average particle size of the crystals is 30 nm or more and 300 nm or less. (Configuration 4) Any of the above-mentioned phthalocyanine compounds containing an atom with an atomic number of 11 or more. The method for generating singlet oxygen described above. (Configuration 5) 5. The method for generating singlet oxygen according to any one of configurations 1 to 4, wherein the phthalocyanine compound is a metal phthalocyanine compound having a central metal atom. (Configuration 6) 6. The method for generating singlet oxygen according to claim 5, wherein the central metal atom is an atom with an atomic number of 11 or more. (Configuration 7) The method for generating singlet oxygen according to the above-mentioned embodiment 5 or 6, wherein the metal phthalocyanine compound has an axial ligand. (Configuration 8) 8. The method for generating singlet oxygen according to claim 7, wherein the axial ligand is a halogen atom or a hydroxyl group. (Configuration 9) A method for generating singlet oxygen according to any one of configurations 1 to 8, characterized in that in the X-ray diffraction pattern, multiple peaks are present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the top two peaks with the highest intensities within the range is 0.70° or less. (Configuration 10) 10. The method for generating singlet oxygen according to any one of claims 1 to 9, wherein the crystal of the phthalocyanine compound is a crystal of a gallium phthalocyanine compound or a titanyl phthalocyanine compound. (Configuration 11) The crystal of the phthalocyanine compound is a compound represented by the following formula (1): [ka] (In formula (1), X 1 represents a hydrogen atom, a methyl group, or an ethyl group; X 2 represents a hydrogen atom, a methyl group, or an ethyl group. 11. The method for generating singlet oxygen according to any one of configurations 1 to 10, comprising: (Configuration 12) The crystal of the phthalocyanine compound is a compound represented by the following formula (2): [ka] (In formula (2), X 1 represents a hydrogen atom, a methyl group, or an ethyl group. 12. The method for generating singlet oxygen according to claim 11, comprising: (Configuration 13) 13. The method for generating singlet oxygen according to claim 11, wherein the content of the compound represented by formula (1) in the crystal of the phthalocyanine compound is 0.10% by mass or more and 1.70% by mass or less. (Configuration 14) A crystal of a phthalocyanine compound; an apparatus having a source for irradiating the crystal with electromagnetic radiation; Equipped with In an X-ray diffraction pattern of a crystal of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak is present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the most intense peak within the range is 2.50° or less; Singlet oxygen is generated from the crystal. Singlet oxygen generating system. (Configuration 15) 15. The singlet oxygen generating system according to claim 14, wherein the wavelength of the electromagnetic radiation is 0.001 nm or more and 10 nm or less. (Configuration 16) A crystal of a phthalocyanine compound; a source for irradiating the crystal with electromagnetic radiation; Equipped with In an X-ray diffraction pattern of a crystal of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak is present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the most intense peak within the range is 2.50° or less; Singlet oxygen is generated from the crystal. Singlet oxygen generator kit. (Configuration 17) 17. The singlet oxygen generating kit according to claim 16, wherein the electromagnetic radiation has a wavelength of 0.001 nm or more and 10 nm or less. (Configuration 18) Contains crystals of a phthalocyanine compound, In an X-ray diffraction pattern of a crystal of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak is present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the most intense peak within the range is 2.50° or less; A singlet oxygen generator that generates singlet oxygen by irradiating the crystal with electromagnetic radiation. (Configuration 19) 19. The singlet oxygen generator according to aspect 18, wherein the number-average particle size of the crystals is 30 nm or more and 300 nm or less. (Configuration 20) 20. The singlet oxygen generator according to claim 18 or 19, wherein the phthalocyanine compound contains an atom with an atomic number of 11 or more. (Configuration 21) 21. The singlet oxygen generator according to any one of configurations 18 to 20, wherein the phthalocyanine compound is a metal phthalocyanine compound having a central metal atom. (Configuration 22) 22. The singlet oxygen generator according to claim 21, wherein the central metal atom is an atom with an atomic number of 11 or more. (Configuration 23) 23. The singlet oxygen generator according to claim 21 or 22, wherein the metal phthalocyanine compound has an axial ligand. (Configuration 24) 24. The singlet oxygen generator according to claim 23, wherein the axial ligand is a halogen atom or a hydroxyl group. (Configuration 25) The singlet oxygen generator according to any one of configurations 18 to 24, characterized in that in the X-ray diffraction pattern, a plurality of peaks are present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the top two peaks with the highest intensities within the range is 0.70° or less. (Configuration 26) 26. The singlet oxygen generator according to any one of Configurations 18 to 25, wherein the crystal of the phthalocyanine compound is a crystal of a gallium phthalocyanine compound or a titanyl phthalocyanine compound. (Configuration 27) The crystal of the phthalocyanine compound is a compound represented by the following formula (1): [ka] (In formula (1), X 1 represents a hydrogen atom, a methyl group, or an ethyl group; X 2 represents a hydrogen atom, a methyl group, or an ethyl group. 27. The singlet oxygen generator according to any one of claims 18 to 26, comprising: (Configuration 28) The crystal of the phthalocyanine compound is a compound represented by the following formula (2): [ka] (In formula (2), X 1 represents a hydrogen atom, a methyl group, or an ethyl group. 28. The singlet oxygen generator according to claim 27, comprising: (Configuration 29) 29. The singlet oxygen generator according to claim 27 or 28, wherein the content of the compound represented by formula (1) in the crystal of the phthalocyanine compound is 0.1% by mass or more and 1.7% by mass or less.
Claims
1. A method for generating singlet oxygen, comprising the steps of: The generating method includes a step of generating singlet oxygen by irradiating a crystal of a phthalocyanine compound with electromagnetic radiation, In an X-ray diffraction pattern of the crystals of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak exists within a diffraction angle range of 2θ=5° to 35°, A method for generating singlet oxygen, characterized in that the half-width of the most intense peak within the range is 2.50° or less.
2. The method for generating singlet oxygen according to claim 1 , wherein the electromagnetic radiation has a wavelength of 0.001 nm or more and 10 nm or less.
3. 3. The method for generating singlet oxygen according to claim 1, wherein the number average particle size of the crystals is 30 nm or more and 300 nm or less.
4. The method for generating singlet oxygen according to claim 1 or 2, wherein the phthalocyanine compound contains an atom with an atomic number of 11 or more.
5. 3. The method for generating singlet oxygen according to claim 1, wherein the phthalocyanine compound is a metal phthalocyanine compound having a central metal atom.
6. The method for generating singlet oxygen according to claim 5 , wherein the central metal atom is an atom having an atomic number of 11 or more.
7. The method for generating singlet oxygen according to claim 5 , wherein the metal phthalocyanine compound has an axial ligand.
8. The method for generating singlet oxygen according to claim 7 , wherein the axial ligand is a halogen atom or a hydroxyl group.
9. The method for generating singlet oxygen according to claim 1 or 2, characterized in that in the X-ray diffraction pattern, a plurality of peaks are present within a range of a diffraction angle 2θ of 5° to 35°, and the half-value width of the top two peaks with the highest intensities within the range is 0.70° or less.
10. 3. The method for generating singlet oxygen according to claim 1, wherein the crystal of the phthalocyanine compound is a crystal of a gallium phthalocyanine compound or a titanyl phthalocyanine compound.
11. The crystal of the phthalocyanine compound is a compound represented by the following formula (1): (In formula (1), X 1 represents a hydrogen atom, a methyl group, or an ethyl group; X 2 represents a hydrogen atom, a methyl group, or an ethyl group. The method for generating singlet oxygen according to claim 1 or 2, comprising:
12. The crystal of the phthalocyanine compound is a compound represented by the following formula (2): (In formula (2), X 1 represents a hydrogen atom, a methyl group, or an ethyl group. The method for generating singlet oxygen according to claim 11, comprising:
13. The method for generating singlet oxygen according to claim 11, wherein the content of the compound represented by formula (1) in the crystal of the phthalocyanine compound is 0.10% by mass or more and 1.70% by mass or less.
14. A crystal of a phthalocyanine compound; an apparatus having a source for irradiating the crystal with electromagnetic radiation; Equipped with In an X-ray diffraction pattern of a crystal of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak is present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the most intense peak within the range is 2.50° or less; Singlet oxygen is generated from the crystal. Singlet oxygen generating system.
15. The singlet oxygen generating system according to claim 14 , wherein the wavelength of the electromagnetic radiation is 0.001 nm or more and 10 nm or less.
16. A crystal of a phthalocyanine compound; a source for irradiating the crystal with electromagnetic radiation; Equipped with In an X-ray diffraction pattern of a crystal of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak is present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the most intense peak within the range is 2.50° or less; Singlet oxygen is generated from the crystal. Singlet oxygen generator kit.
17. The singlet oxygen generating kit according to claim 16, wherein the wavelength of the electromagnetic radiation is 0.001 nm or more and 10 nm or less.
18. Contains crystals of a phthalocyanine compound, In an X-ray diffraction pattern of a crystal of the phthalocyanine compound obtained by X-ray diffraction measurement using CuKα radiation, a peak is present within a diffraction angle 2θ range of 5° to 35°, and the half-value width of the most intense peak within the range is 2.50° or less; A singlet oxygen generator that generates singlet oxygen by irradiating the crystal with electromagnetic radiation.
19. The singlet oxygen generator according to claim 18 , wherein the number average particle size of the crystals is 30 nm or more and 300 nm or less.
20. The singlet oxygen generator according to claim 18 or 19, wherein the phthalocyanine compound contains an atom having an atomic number of 11 or more.
21. The singlet oxygen generator according to claim 18 or 19, wherein the phthalocyanine compound is a metal phthalocyanine compound having a central metal atom.
22. The singlet oxygen generator according to claim 21 , wherein the central metal atom is an atom having an atomic number of 11 or more.
23. The singlet oxygen generator according to claim 21 , wherein the metal phthalocyanine compound has an axial ligand.
24. The singlet oxygen generator according to claim 23 , wherein the axial ligand is a halogen atom or a hydroxy group.
25. The singlet oxygen generator according to claim 18 or 19, characterized in that in the X-ray diffraction pattern, a plurality of peaks are present within a range of a diffraction angle 2θ of 5° to 35°, and the half-value width of the top two peaks with the highest intensities within the range is 0.70° or less.
26. 20. The singlet oxygen generator according to claim 18, wherein the crystal of the phthalocyanine compound is a crystal of a gallium phthalocyanine compound or a titanyl phthalocyanine compound.
27. The crystal of the phthalocyanine compound is a compound represented by the following formula (1): (In formula (1), X 1 represents a hydrogen atom, a methyl group, or an ethyl group; X 2 represents a hydrogen atom, a methyl group, or an ethyl group. The singlet oxygen generator according to claim 18 or 19, comprising:
28. The crystal of the phthalocyanine compound is a compound represented by the following formula (2): (In formula (2), X 1 represents a hydrogen atom, a methyl group, or an ethyl group. The singlet oxygen generator according to claim 27, comprising:
29. 28. The singlet oxygen generator according to claim 27, wherein the content of the compound represented by formula (1) in the crystal of the phthalocyanine compound is 0.1% by mass or more and 1.7% by mass or less.
Citation Information
Patent Citations
X-ray radiotherapy sensitizer
JP2009155239A
Methods and systems for treating cell proliferation disorders
JP2010523690A
Nanoparticles for photodynamic therapy, X-ray-induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof
JP2017532340A
